English A Must In Australian Proposals On Using Overseas Assessments
Executive Summary
Australia believes that using overseas assessment reports will help the Therapeutic Goods Administration cut the time it takes to review drug applications by up to three months. Meanwhile, a work-sharing scheme could make it easier for applicants to enter multiple international markets.
You may also be interested in...
Australia Consults On 150-Day Priority Review, Provisional Approval
Plans for new speedier routes to market are moving ahead as the Australian government announces a public consultation on the proposals for priority review and provisional approval pathways that were announced in September.
Australia Plans New Approval Pathways To Foster Earlier Access To Novel Drugs
The Australian government has come up with a set of proposals for reforming the drug and medical device regulatory framework, which include speeding up access to innovative drugs through expedited and provisional approval mechanisms and greater use of assessments by overseas regulators. The changes will be phased in over a period of about three years and may include some recovery of costs from industry.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.